Cancer vaccines: State of the art of the computational modeling approaches

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Pappalardo, Francesco ^a   Chiacchio, Ferdinando ^a   Motta, Santo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; DNA VACCINE; TUMOR ANTIGEN;

ALGORITHM; B LYMPHOCYTE; BREAST CARCINOGENESIS; CANCER IMMUNIZATION; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER PREVENTION; COMPUTATIONAL MODEL; CYTOTOXICITY; DENDRITIC CELL; DNA IMMUNIZATION; DRUG DESIGN; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; MATHEMATICAL MODEL; METASTASIM MODEL; NEOPLASM; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); REVIEW; SIMTRIPLEX MODEL; T LYMPHOCYTE; ANIMAL; BIOLOGICAL MODEL; COMPUTER SIMULATION; IMMUNOLOGY;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; COMPUTER SIMULATION; HUMANS; MODELS, IMMUNOLOGICAL;

EID: 84874611004     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/106407     Document Type: Review

References (29)

1. Zou W., Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Reviews Cancer 2005 5 4 263 274 2-s2.0-16844379997 10.1038/nrc1586 (Pubitemid 40488632)
2. Gilboa E., The promise of cancer vaccines. Nature Reviews Cancer 2004 4 5 401 411 2-s2.0-2342537869 (Pubitemid 38579486)
3. Guinn B. A., Kasahara N., Farzaneh F., Habib N. A., Norris J. S., Deisseroth A. B., Recent advances and current challenges in tumor immunology and immunotherapy. Molecular Therapy 2007 15 6 1065 1071 2-s2.0-34249321620 10.1038/sj.mt.6300138 (Pubitemid 46813608)
4. Dunn G. P., Old L. J., Schreiber R. D., The three Es of cancer immunoediting. Annual Review of Immunology 2004 22 329 360 2-s2.0-2542430341 10.1146/annurev.immunol.22.012703.104803 (Pubitemid 38680426)
5. Begley J., Ribas A., Targeted therapies to improve tumor immunotherapy. Clinical Cancer Research 2008 14 14 4385 4391 2-s2.0-51649124283 10.1158/1078-0432.CCR-07-4804
6. Bhattacharya-Chatterjee M., Chatterjee S. K., Foon K. A., Anti-idiotype antibody vaccine therapy for cancer. Expert Opinion on Biological Therapy 2002 2 8 869 881 2-s2.0-0036919339 10.1517/14712598.2.8.869 (Pubitemid 36033253)
7. Nestle F. O., Farkas A., Conrad C., Dendritic-cell-based therapeutic vaccination against cancer. Current Opinion in Immunology 2005 17 2 163 169 2-s2.0-14844331400 10.1016/j.coi.2005.02.003 (Pubitemid 40343103)
8. Lollini P.-L., Cavallo F., Nanni P., Forni G., Vaccines for tumour prevention. Nature Reviews Cancer 2006 6 3 204 216 2-s2.0-33644534148 10.1038/nrc1815 (Pubitemid 43292564)
9. Kumar N., Hendriks B. S., Janes K. A., de Graaf D., Lauffenburger D. A., Applying computational modeling to drug discovery and development. Drug Discovery Today 2006 11 17-18 806 811 2-s2.0-33747812085 10.1016/j.drudis.2006. 07.010 (Pubitemid 44280026)
10. He Y., Rappuoli R., De Groot A. S., Chen R. T., Emerging vaccine informatics. Journal of Biomedicine and Biotechnology 2010 2010 26 218590 10.1155/2010/218590
11. Pappalardo F., Lollini P.-L., Castiglione F., Motta S., Modeling and simulation of cancer immunoprevention vaccine. Bioinformatics 2005 21 12 2891 2897 2-s2.0-20844453250 10.1093/bioinformatics/bti426 (Pubitemid 40862289)
12. Nanni P., Nicoletti G., De Giovanni C., Landuzzi L., Di Carlo E., Cavallo F., Pupa S. M., Rossi I., Colombo M. P., Ricci C., Astolfi A., Musiani P., Forni G., Lollini P. L., Combined allogeneic tumor cell vaccination and systematic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. Journal of Experimental Medicine 2001 194 9 1195 1205 2-s2.0-0035163903 10.1084/jem.194.9.1195 (Pubitemid 33055039)
13. Palladini A., Nicoletti G., Pappalardo F., Murgo A., Grosso V., Stivani V., Ianzano M. L., Antognoli A., Croci S., Landuzzi L., De Giovanni C., Nanni P., Motta S., Lollini P. L., In silico modeling and in vivo efficacy of cancer-preventive vaccinations. Cancer Research 2010 70 20 7755 7763 2-s2.0-78049276724 10.1158/0008-5472.CAN-10-0701
14. Pappalardo F., Pennisi M., Castiglione F., Motta S., Vaccine protocols optimization: in silico experiences. Biotechnology Advances 2010 28 1 82 93 2-s2.0-71249110111 10.1016/j.biotechadv.2009.10.001
15. Nanni P., Nicoletti G., Palladini A., Croci S., Murgo A., Antognoli A., Landuzzi L., Fabbi M., Ferrini S., Musiani P., Iezzi M., De Giovanni C., Lollini P. L., Antimetastatic activity of a preventive cancer vaccine. Cancer Research 2007 67 22 11037 11044 2-s2.0-36348966738 10.1158/0008-5472.CAN-07-2499 (Pubitemid 350145934)
16. Pennisi M., Pappalardo F., Palladini A., Nicoletti G., Nanni P., Lollini P. L., Motta S., Modeling the competition between lung metastases and the immune system using agents. BMC Bioinformatics 2010 11 supplement 7, article S13 2-s2.0-77957924286 10.1186/1471-2105-11-S7-S13
17. Pappalardo F., Mastriani E., Lollini P.-L., Motta S., Genetic algorithm against cancer. 3849 Proceedings of the 6th international conference on Fuzzy Logic and Applications (WILF '06) 2006 223 228 Lecture Notes in Computer Science
18. Pennisi M., Catanuto R., Pappalardo F., Motta S., Optimal vaccination schedules using simulated annealing. Bioinformatics 2008 24 15 1740 1742 2-s2.0-48249129088 10.1093/bioinformatics/btn260
19. Pappalardo F., Palladini A., Pennisi M., Castiglione F., Motta S., Mathematical and computational models in tumor immunology. Mathematical Modelling of Natural Phenomena 2012 7 3 186 203
20. Alemani D., Pappalardo F., Pennisi M., Motta S., Brusic V., Combining cellular automata and lattice boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition. Journal of Immunological Methods 2012 376 1-2 55 68
21. Pappalardo F., Forero I. M., Pennisi M., Palazon A., Melero I., Motta S., Simb16: modeling induced immune system response against b16-melanoma. PLoS ONE 2011 6 10
22. Joshi B., Wang X., Banerjee S., Tian H., Matzavinos A., Chaplain M. A. J., On immunotherapies and cancer vaccination protocols: a mathematical modelling approach. Journal of Theoretical Biology 2009 259 4 820 827 2-s2.0-67650756469 10.1016/j.jtbi.2009.05.001
23. Mishra S., Sinha S., Immunoinformatics and modeling perspective of T cell epitope-based cancer immunotherapy: a holistic picture. Journal of Biomolecular Structure and Dynamics 2009 27 3 293 306 2-s2.0-70349912672
24. DeLuca D. S., Blasczyk R., The immunoinformatics of cancer immunotherapy. Tissue Antigens 2007 70 4 265 271 2-s2.0-34548370670 10.1111/j.1399-0039.2007. 00914.x (Pubitemid 47340739)
25. Iurescia S., Fioretti D., Fazio V. M., Rinaldi M., Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge. Biotechnology Advances 2012 30 372 383 2-s2.0-79960608647 10.1016/j.biotechadv.2011.06.020
26. Zhang G. L., Lin H. H., Keskin D. B., Reinherz E. L., Brusic V., Dana-Farber repository for machine learning in immunology. Journal of Immunological Methods 2011 374 18 25 2-s2.0-79960986414 10.1016/j.jim.2011.07. 007
27. Frelinger J., Ottinger J., Gouttefangeas C., Chan C., Modeling flow cytometry data for cancer vaccine immune monitoring. Cancer Immunology, Immunotherapy 2010 59 9 1435 1441 2-s2.0-77955512886 10.1007/s00262-010-0883-4
28. Kogan Y., Halevi-Tobias K., Elishmereni M., Vuk-Pavlovic S., Agur Z., Reconsidering the paradigm of cancer immunotherapy by computationally aided real-time personalization. Cancer Research 2012 72 9 2218 2227
29. Wilson S., Levy D., A mathematical model of the enhancement of tumor Vaccine efficacy by immunotherapy. Bulletin of Mathematical Biology 2012 74 1485 1500